Rezolute, Inc. (NASDAQ:RZLT) Receives $9.67 Average PT from Analysts

Rezolute, Inc. (NASDAQ:RZLTGet Free Report) has been assigned an average rating of “Buy” from the six ratings firms that are currently covering the firm, Marketbeat Ratings reports. Six research analysts have rated the stock with a buy rating. The average 12 month target price among analysts that have issued ratings on the stock in the last year is $9.67.

Several research firms recently weighed in on RZLT. JMP Securities reaffirmed a “market outperform” rating and set a $7.00 target price on shares of Rezolute in a research note on Thursday, April 18th. Maxim Group started coverage on Rezolute in a research report on Tuesday, April 9th. They set a “buy” rating and a $8.00 price objective for the company. Jonestrading began coverage on Rezolute in a report on Thursday, April 18th. They set a “buy” rating and a $10.00 price target for the company. Craig Hallum initiated coverage on Rezolute in a report on Tuesday. They set a “buy” rating and a $14.00 price objective on the stock. Finally, HC Wainwright reaffirmed a “buy” rating and set a $14.00 price target on shares of Rezolute in a research note on Wednesday, May 22nd.

Check Out Our Latest Stock Report on RZLT

Insider Buying and Selling at Rezolute

In other Rezolute news, CFO Daron Evans bought 20,000 shares of the business’s stock in a transaction on Friday, March 15th. The shares were acquired at an average price of $1.69 per share, with a total value of $33,800.00. Following the transaction, the chief financial officer now owns 20,000 shares of the company’s stock, valued at approximately $33,800. The purchase was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders bought a total of 38,509 shares of company stock valued at $75,794 in the last ninety days. Corporate insiders own 20.80% of the company’s stock.

Institutional Trading of Rezolute

Several hedge funds and other institutional investors have recently bought and sold shares of RZLT. Virtu Financial LLC bought a new stake in shares of Rezolute in the 1st quarter valued at about $37,000. Affinity Asset Advisors LLC purchased a new stake in Rezolute during the first quarter valued at approximately $4,080,000. Acadian Asset Management LLC acquired a new stake in Rezolute in the first quarter valued at approximately $229,000. Vanguard Group Inc. grew its holdings in Rezolute by 10.4% in the first quarter. Vanguard Group Inc. now owns 1,553,352 shares of the company’s stock worth $3,961,000 after purchasing an additional 145,700 shares during the last quarter. Finally, Rosalind Advisors Inc. acquired a new position in shares of Rezolute during the first quarter worth $510,000. Institutional investors own 82.97% of the company’s stock.

Rezolute Stock Down 3.5 %

Shares of NASDAQ:RZLT opened at $5.59 on Tuesday. The firm’s 50 day moving average price is $3.11 and its 200-day moving average price is $1.88. The stock has a market capitalization of $224.33 million, a PE ratio of -4.90 and a beta of 1.31. Rezolute has a twelve month low of $0.72 and a twelve month high of $6.10.

Rezolute (NASDAQ:RZLTGet Free Report) last announced its quarterly earnings data on Wednesday, May 15th. The company reported ($0.34) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.34). Analysts expect that Rezolute will post -1.15 earnings per share for the current fiscal year.

About Rezolute

(Get Free Report

Rezolute, Inc, a clinical stage biopharmaceutical company, develops therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder.

Read More

Analyst Recommendations for Rezolute (NASDAQ:RZLT)

Receive News & Ratings for Rezolute Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rezolute and related companies with MarketBeat.com's FREE daily email newsletter.